KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 126 filers reported holding KALA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $23,253,000 | -0.6% | 3,450,000 | 0.0% | 0.34% | -3.9% |
| Q4 2020 | $23,391,000 | -9.6% | 3,450,000 | 0.0% | 0.36% | -29.2% |
| Q3 2020 | $25,875,000 | -28.6% | 3,450,000 | 0.0% | 0.51% | -35.7% |
| Q2 2020 | $36,259,000 | +39.7% | 3,450,000 | +16.8% | 0.79% | -6.3% |
| Q1 2020 | $25,956,000 | +1794.6% | 2,952,899 | +4821.5% | 0.84% | +978.2% |
| Q3 2017 | $1,370,000 | – | 60,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,727,751 | $4,527,000 | 3.67% |
| RA Capital Management | 10,874,613 | $28,491,000 | 0.40% |
| ACT CAPITAL MANAGEMENT, LLC | 190,000 | $498,000 | 0.26% |
| Samsara BioCapital, LLC | 601,162 | $1,575,000 | 0.25% |
| Orbimed Advisors | 3,438,998 | $9,010,000 | 0.10% |
| Towercrest Capital Management | 122,500 | $321,000 | 0.06% |
| Knights of Columbus Asset Advisors LLC | 236,757 | $620,000 | 0.06% |
| Matisse Capital | 56,100 | $147,000 | 0.05% |
| Taylor Wealth Management Partners | 43,990 | $115,000 | 0.04% |
| SYMONS CAPITAL MANAGEMENT INC | 14,346 | $37,000 | 0.02% |